Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial
Qihan Fu, Yiwen Chen, Dabing Huang, Chengxiang Guo, Xiaochen Zhang, Wenbo Xiao, Xing Xue, Qi Zhang, Xiang Li, Shunliang Gao, Risheng Que, Yan Shen, Jian Wu, Min Zhang, Xueli Bai, Tingbo Liang
Topics & Concepts
MedicineFOLFIRINOXFolinic acidInternal medicineIrinotecanHazard ratioOxaliplatinClinical endpointGastroenterologyPancreatic cancerPopulationGemcitabineOncologyConfidence intervalRandomized controlled trialFluorouracilCancerColorectal cancerEnvironmental healthPancreatic and Hepatic Oncology ResearchCancer Research and TreatmentsPeptidase Inhibition and Analysis